arrow
M

Michał Wągrodzki

Maria Sklodowska-Curie National Research Institute of Oncology
H指数:16
被引数:832

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma

整合免疫与分子图谱分析可识别软骨肉瘤中的预后亚群和 therapeutic targets

2026-02-200
PRE
Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in Europe

探索NGS对肉瘤诊断和治疗的影响:来自欧洲多机构真实世界数据的见解

2025-09-110
OAAI
Extraskeletal mesenchymal chondrosarcoma: oligometastatic disease and effect of multimodal treatment

Remiszewski, P.; Spałek, M.J.; Koseła-Paterczyk, H.; Wągrodzki, M.; Kalinowska, I.; Rutkowski, P.; Czarnecka, A.M. 骨外间充质软骨肉瘤:寡转移性疾病及多模式治疗效果。Oncol. Clin. Pract. 2025. [Google Scholar] [CrossRef]

2025-09-011
OAAI
Immunological-molecular profiling of chondrosarcoma (ChS)

免疫学-分子分型分析软骨肉瘤(ChS)

2024-09-010
PRE
Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial
2021-07-0121
PRE